The prevalence of antenatal and postnatal co-morbid anxiety and depression: a meta-analysis
- PMID: 28414017
- DOI: 10.1017/S0033291717000617
The prevalence of antenatal and postnatal co-morbid anxiety and depression: a meta-analysis
Abstract
To date, the precise prevalence of co-morbidity of anxiety and depression in the perinatal period is not well known. We aimed to estimate the prevalence of co-morbid anxiety and depression in the antenatal and postnatal periods. Systematic searches of multiple electronic databases were conducted for studies published between January 1950 and January 2016. We included 66 (24 published and 42 unpublished) studies incorporating 162 120 women from 30 countries. Prevalence of self-reported antenatal anxiety symptoms and mild to severe depressive symptoms was 9.5% [95% confidence interval (CI) 7.8-11.2, 17 studies, n = 25 592] and of co-morbid anxiety symptoms and moderate/severe depressive symptoms was 6.3% (95% CI 4.8-7.7, 17 studies, n = 27 270). Prevalence of a clinical diagnosis of any antenatal anxiety disorder and depression was 9.3% (95% CI 4.0-14.7, 10 studies, n = 3918) and of co-morbid generalized anxiety disorder and depression was 1.7% (95% CI 0.2-3.1, three studies, n = 3085). Postnatally between 1 and 24 weeks postpartum, the prevalence of co-morbid anxiety symptoms and mild to severe depressive symptoms was 8.2% (95% CI 6.5-9.9, 15 studies, n = 14 731), while co-morbid anxiety symptoms and moderate/severe depressive symptoms was 5.7% (95% CI 4.3-7.1, 13 studies, n = 20 849). The prevalence of a clinical diagnosis of co-morbid anxiety and depression was 4.2% (95% CI 1.9-6.6, eight studies, n = 3251). Prevalence rates did not differ with regard to year of publication, country income, selection bias and attrition bias. The results suggest that co-morbid perinatal anxiety and depression are prevalent and warrant clinical attention given the potential negative child developmental consequences if left untreated. Further research is warranted to develop evidence-based interventions for prevention, identification and treatment of this co-morbidity.
Keywords: Anxiety; depression; perinatal period; postnatal period; pregnancy.
Similar articles
-
Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis.Br J Psychiatry. 2017 May;210(5):315-323. doi: 10.1192/bjp.bp.116.187179. Epub 2017 Mar 16. Br J Psychiatry. 2017. PMID: 28302701 Review.
-
Depression and anxiety in perinatal period: prevalence and risk factors in an Italian sample.Arch Womens Ment Health. 2012 Feb;15(1):21-30. doi: 10.1007/s00737-011-0249-8. Epub 2011 Dec 29. Arch Womens Ment Health. 2012. PMID: 22205237
-
The course of anxiety and depression through pregnancy and the postpartum in a community sample.J Affect Disord. 2004 May;80(1):65-73. doi: 10.1016/j.jad.2003.08.004. J Affect Disord. 2004. PMID: 15094259
-
Social determinants of antenatal depression and anxiety among women in South Asia: A systematic review & meta-analysis.PLoS One. 2022 Feb 9;17(2):e0263760. doi: 10.1371/journal.pone.0263760. eCollection 2022. PLoS One. 2022. PMID: 35139136 Free PMC article.
-
Global prevalence of perinatal depression and anxiety during the COVID-19 pandemic: An umbrella review and meta-analytic synthesis.Acta Obstet Gynecol Scand. 2024 Feb;103(2):210-224. doi: 10.1111/aogs.14740. Epub 2023 Dec 19. Acta Obstet Gynecol Scand. 2024. PMID: 38113292 Free PMC article. Review.
Cited by
-
Disparities in Utilization and Delivery Outcomes for Women with Perinatal Mood and Anxiety Disorders.J Psychiatr Brain Sci. 2024;9(2):e240003. doi: 10.20900/jpbs.20240003. Epub 2024 Apr 30. J Psychiatr Brain Sci. 2024. PMID: 38817312 Free PMC article.
-
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions.Drugs. 2024 Jun;84(6):645-659. doi: 10.1007/s40265-024-02038-z. Epub 2024 May 30. Drugs. 2024. PMID: 38811474 Review.
-
Social determinants of antidepressant continuation during pregnancy in the USA: findings from the ABCD cohort study.Arch Womens Ment Health. 2024 May 14. doi: 10.1007/s00737-024-01470-0. Online ahead of print. Arch Womens Ment Health. 2024. PMID: 38740587
-
Patterns of peripartum depression and anxiety during the pre-vaccine COVID-19 pandemic.BMC Pregnancy Childbirth. 2024 Apr 25;24(1):310. doi: 10.1186/s12884-024-06518-8. BMC Pregnancy Childbirth. 2024. PMID: 38664729 Free PMC article.
-
Does preterm birth increase the initiation of antidepressant use during the postpartum? A population-based investigation.Front Pharmacol. 2024 Mar 27;15:1325381. doi: 10.3389/fphar.2024.1325381. eCollection 2024. Front Pharmacol. 2024. PMID: 38601467 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical